RESEARCH PEPTIDE
Tirzepatide 10 mg
Tirzepatide 10 mg
Tirzepatide is a dual GIP/GLP-1 receptor agonist studied for coordinated incretin signalling and glucose-dependent metabolic pathways.
Quality documentation
Certificate of Analysis Available
View the available testing documentation for Tirzepatide 10 mg.
IDR 1.799.000
- Product
- Tirzepatide
- Strength
- 10 mg
- Category
- Research Peptides
- Purity
- ≥99.6% PURITY
- Use
- Laboratory and scientific research only
- Price
- IDR 1.799.000
The power of dual-incretin receptor research.
Tirzepatide is a dual GIP/GLP-1 receptor agonist studied for coordinated incretin signalling and glucose-dependent metabolic pathways.
Research context
Preclinical characterisation examines coordinated GIP and GLP-1 receptor agonism, downstream cAMP signalling, and glucose-dependent metabolic responses. This mechanism-led profile does not promise weight-loss, glycaemic, appetite, or cardiovascular outcomes.
Research interests
- GIP receptor signalling
- GLP-1 receptor signalling
- Glucose-dependent metabolic pathways
Explore further
Related research products
Research Peptides≥99.6% PURITY10 mg
AOD-9604 is a modified C-terminal growth-hormone fragment studied in preclinical lipid-metabolism, fat-oxidation, and adipose-signalling models.
≥99.6% PURITY
IDR 3.499.000
Research Peptides≥99.6% PURITY10 mg
BPC-157 is studied in preclinical models of tendon-fibroblast migration, FAK–paxillin activation, and tissue-repair signalling.
≥99.6% PURITY
IDR 1.199.000
Research Peptides≥99.6% PURITY5 mg
CJC-1295 is studied within growth hormone-releasing hormone research for its influence on GH and IGF-1 signalling.
≥99.6% PURITY
IDR 1.399.000
Research Peptides≥99.6% PURITY10 mg
DSIP is an exploratory neuropeptide studied at the intersection of slow-wave EEG activity, sleep signalling, and neuroendocrine regulation.
≥99.6% PURITY
IDR 2.199.000